In T-ALL cells as well as B-ALL cells featuring MLL or BCR-ABL1 rearrangements, palbociclib controlled cell growth via G1 arrest and Rb dephosphorylation both in vitro and in vivo [14,25,26,27,28]. Here, KMT2A is linked to acute lymphoblastic leukemia.